BLUEPRINT MEDICINES CORP's ticker is BPMC and the CUSIP is 09627Y109. A total of 233 filers reported holding BLUEPRINT MEDICINES CORP in Q4 2019. The put-call ratio across all filers is 1.49 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $1,551,798 | -5.2% | 30,900 | +19.3% | 0.02% | -6.2% |
Q2 2023 | $1,636,880 | +54.8% | 25,900 | +10.2% | 0.02% | +45.5% |
Q1 2023 | $1,057,265 | +10.2% | 23,500 | +7.3% | 0.01% | +10.0% |
Q4 2022 | $959,439 | -14.3% | 21,900 | +28.8% | 0.01% | -23.1% |
Q3 2022 | $1,120,130 | +11.0% | 17,000 | +7.6% | 0.01% | +44.4% |
Q1 2022 | $1,009,000 | -38.0% | 15,800 | +3.9% | 0.01% | -18.2% |
Q4 2021 | $1,628,000 | -40.5% | 15,200 | -42.9% | 0.01% | -60.7% |
Q3 2021 | $2,735,000 | -1.3% | 26,600 | -15.6% | 0.03% | +3.7% |
Q2 2021 | $2,771,000 | +8.4% | 31,500 | +19.8% | 0.03% | +8.0% |
Q1 2021 | $2,557,000 | +37.3% | 26,300 | +58.4% | 0.02% | +25.0% |
Q4 2020 | $1,862,000 | +58.2% | 16,600 | +30.7% | 0.02% | +53.8% |
Q3 2020 | $1,177,000 | +201.8% | 12,700 | +154.0% | 0.01% | +160.0% |
Q2 2020 | $390,000 | -45.9% | 5,000 | -44.4% | 0.01% | -37.5% |
Q4 2019 | $721,000 | – | 9,000 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
TRV GP II, LLC | 878,875 | $70,354,000 | 45.87% |
CVI Holdings, LLC | 200,000 | $16,010,000 | 15.16% |
Foresite Capital Management III, LLC | 467,682 | $37,438,000 | 9.74% |
Casdin Capital, LLC | 848,648 | $67,934,000 | 7.46% |
BVF INC/IL | 564,965 | $45,225,000 | 5.06% |
Ghost Tree Capital, LLC | 240,000 | $19,212,000 | 5.02% |
DAFNA Capital Management LLC | 119,718 | $9,583,000 | 4.13% |
HHLR ADVISORS, LTD. | 1,498,516 | $119,956,000 | 3.34% |
Opaleye Management Inc. | 130,000 | $10,407,000 | 2.88% |
Perceptive Advisors | 1,271,054 | $101,748,000 | 2.87% |